PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China.\', \'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR), PR China.\', \'Kunming University of Science and Technology Library, Kunming, PR China.\', \'Technology Centre, Guangzhou Customs, PR China.\', \'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau SAR, PR China; KingMed Virology DiagnoStic & Translational Center, PR China. Electronic address: jeffyah@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1043-6618(20)31158-010.1016/j.phrs.2020.104850
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 32360580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all